Table 1 Characteristics HBV patients segregated according to clinical presentation.

Age (years)

42 [21–85]

57 [27–79]

55 [23–92]

<0.05^β

Male (%)

81

78

91

NS^α

AST (IU/L)

96 [35–293]

69 [50–134]

69 [48–123]

NS^β

ALT (IU/L)

117 [36–453]

46 [29–85]

44 [30–84]

<0.0001^β

Total bilirubin (mg/dl)

16 [12–61]

31 [22–58]

15 [11–20]

<0.0001^β

Direct bilirubin (mg/dl)

5 [3–50]

15 [8–33]

4 [3–6]

<0.0001^β

Albumin (g/L)

41 [38–43]

32 [28–38]

39 [35–42]

<0.0001^β

Prothrombin (% of standard)

95 [81–108]

65 [53–79]

95 [85–106]

<0.0014^β

WBC (x10³/ml)

7.0 [5.6–8.6]

5.0 [4.3–6.7]

7.0 [5.7–8.7]

<0.0001^β

RBC (x10⁶/ml)

5.0 [4.6–5.3)

4.0 [3.4–4.2]

5.0 [4.3–5.2)

<0.0001^β

PLT (x10³/ml)

191 [153–237]

88 [64–113]

194 [142–238]

<0.0001^β

HBV-DNA - log10(copies/ml)

6.0 [4.4–8.0]

5.2 [3.9–7.8]

5.0 [4.2–6.6]

NS ^β

AFP (IU/L)

2.0 [1.5–9.3]

11.0 [4.0–25.8]

126.0 [12.9–315.2]

<0.0001^β